Sep 28 2009
MedPro Safety Products, Inc. (OTCBB: MPSP), a pioneer in the development and marketing of passive needlestick injury prevention technology, entered into an exclusive agreement with Advanced MedTech (AMT). AMT is wholly owned by Hooman Asbgahi, the inventor of MedPro’s phlebotomy products, marketed by Greiner Bio-One GmbH under its VACUETTE® brand as the VACUETTE® PREMIUM Safety Needle System and VACUETTE® PREMIUM Blood Collection Set.
Under the agreement’s terms, AMT will provide MedPro with R&D, market research, product design and development, engineering and other services as directed by MedPro. MedPro has the first right of refusal to all intellectual property in which Mr. Asbaghi has an interest and products he develops.
“This exclusive agreement with Advanced MedTech solidifies our relationship with one of the leading innovators in passive needlestick injury prevention,” said Walter Waller, MedPro President and COO. “We believe that Mr. Asbaghi’s VACUETTE® fully-passive designs provide healthcare providers with superior needlestick risk management, and with our manufacturing and distribution partner, Greiner Bio-One GmbH, we are very excited to introduce them to the marketplace. We foresee a long and fruitful relationship with Mr. Asbaghi as we work together to develop new passive technologies for our product portfolio.”
FDA strengthens AI regulation to ensure patient safety and innovation in healthcare